Cairo – Mubasher: Nile Pharmaceuticals and Chemical Industries said Wednesday that its board has approved the estimated budget draft for fiscal year 2017/2018.
The company targets a net profit before tax of EGP 32 million in FY17/18, with an increase of 3.2% compared to a profit worth EGP 31 million for FY16/17, according to a bourse statement.
Nile Pharmaceuticals eyes EGP 570 million revenues for the next FY, 37.3% up from EGP 415 million for FY16/17.
The stock was last traded at EGP 9.97.
